Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis

RecruitingOBSERVATIONAL

Enrollment

128

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2032

Conditions

Head and Neck Squamous Cell CarcinomaLocally Advanced Stage

Interventions

OTHER

Biomarkers evaluation

Evaluate the prognostic role of the markers TP53, P16, Cyclin D1, EGFR, Akt, PDL-1, ERCC1 examined on biopsy samples.

Trial Locations (1)

RECRUITING

"Istituto Nazionale Tumori , Fondazione Pascale"

All Listed Sponsors

lead

National Cancer Institute, Naples

OTHER